SST and Alzheimer disease: Our findings confirm prior evidence of preferential loss of SST+ interneurons in AD and, for the first time to our knowledge, show that SST signaling dynamics in the entorhinal cortex reflect the pattern of vulnerability seen in AD and preservation in resilience, positioning molecular inhibitory systems in resilience as an intermediate state along the AD trajectory.